摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

calphostin D

中文名称
——
中文别名
——
英文名称
calphostin D
英文别名
ent-isophleichrome;isocalphostin D;ent-Phleichrome;UCN-1028 D;(+)-phleichrome;UCN-1028 iso-D
calphostin D化学式
CAS
——
化学式
C30H30O10
mdl
——
分子量
550.562
InChiKey
LNDBGVYRENMDEN-VXGBXAGGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.19
  • 重原子数:
    40.0
  • 可旋转键数:
    8.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    151.98
  • 氢给体数:
    4.0
  • 氢受体数:
    10.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    calphostin D氧气 作用下, 以 乙腈 为溶剂, 反应 2.0h, 生成 peroxypleichrome
    参考文献:
    名称:
    几种天然醌类真菌毒素光动力效率的比较评价
    摘要:
    摘要 一些醌类真菌代谢的光动力效率量表在体外测量为油酸甲酯产生的氢过氧化物的量
    DOI:
    10.1016/0031-9422(88)80423-0
  • 作为产物:
    描述:
    calphostin A甲醇sodium methylate 作用下, 以66%的产率得到calphostin D
    参考文献:
    名称:
    复杂天然产物合成中的卡宾配合物:Calphostins 的全合成
    摘要:
    Calphostin A、B、C 和 D (1-4) 于 1989 年从日本大阪发现的真菌 Cladosporium cladosporioides 中分离出来,属于一类天然存在的苝醌。 1,2 Calphostin 被发现是有效的特异性抑制剂蛋白激酶 C (PKC) 并表现出强烈的细胞毒活性,但没有抗真菌或抗生素活性。3 有趣的是,这种生物活性也被发现是光依赖性的,4 尽管具体机制尚未阐明。PKC 代表细胞内信号通路的一个分支,它的过度刺激与从癌症到糖尿病的多种疾病状态有关。 5 作为不受控制的细胞增殖的特定介质,通过它们对蛋白激酶 C 的作用,钙磷蛋白作为抗癌治疗的潜在药物引起了相当大的关注。6 事实上,已经报道了该组中最简单成员的三种全合成。7 然而,这些合成需要从市售材料中进行 20 多个步骤和/或缺乏有效控制轴向手性。此外,迄今为止尚未报道该组中最具生物活性的钙磷蛋白 C 的全合成。我们在此报告了
    DOI:
    10.1021/ja994313+
点击查看最新优质反应信息

文献信息

  • Total Synthesis of the Calphostins:  Application of Fischer Carbene Complexes and Thermodynamic Control of Atropisomers
    作者:Craig A. Merlic、Courtney C. Aldrich、Jennifer Albaneze-Walker、Alan Saghatelian、Jerome Mammen
    DOI:10.1021/jo0014663
    日期:2001.2.1
    perylenequinones. Thermal equilibration to a 3:1 P:M atropisomeric ratio and separation of the perylenequinones followed by side chain desymmetrization and functionalization led to the total synthesis of enantio- and diastereomerically pure calphostin C in only twelve steps from commercially available starting materials. In addition, calphostins A, B, D, and several structural analogues were prepared to evaluate
    据报道有效的蛋白激酶C抑制剂蛋白A,B,C和D以及各种结构类似物的总合成。利用对映纯舍尔卡宾络合物的苯甲酸酯化反应制备五取代的胺。优化侧链取代基后,将胺转化为邻醌,然后使用三氟乙酸和空气进行仿生氧化二聚,得到阻转异构体per醌的1:2 P / M混合物。热平衡至3:1 P:M的对映异构体比例,并分离出ylene醌,然后进行侧链去对称和官能化,仅用十二个步骤就可以从市售起始原料完全合成对映体和非对映体纯黄素C。此外,
  • Perylenequinone Natural Products: Total Syntheses of the Diastereomers (+)-Phleichrome and (+)-Calphostin D by Assembly of Centrochiral and Axial Chiral Fragments
    作者:Barbara J. Morgan、Carol A. Mulrooney、Erin M. O’Brien、Marisa C. Kozlowski
    DOI:10.1021/jo901384h
    日期:2010.1.1
    utilize an enantiopure biaryl common intermediate, which is formed via an enantioselective catalytic biaryl coupling. The established axial chirality is transferred to the perylenequinone helical stereochemistry with good fidelity. Additionally, efforts focused on the installation of the stereogenic C7,C7′-2-hydroxypropyl groups. Three routes were evaluated to establish the C7,C7′-stereochemistry, in which
    概述了 (+)-calphostin D 的第一次全合成和 (+)-phleichrome 的全合成。收敛合成利用对映纯的联芳基共同中间体,其通过对映选择性催化联芳基偶联形成。建立的轴向手性以良好的保真度转移到醌螺旋立体化学。此外,努力集中在立体 C7,C7'-2-羟丙基基团的安装上。评估了三种路线以建立 C7,C7'-立体化学,其中成功的路线涉及具有复杂轴向手性双酸盐的双环氧化物烷基化。
  • Design, Synthesis, and Investigation of Protein Kinase C Inhibitors: Total Syntheses of (+)-Calphostin D, (+)-Phleichrome, Cercosporin, and New Photoactive Perylenequinones
    作者:Barbara J. Morgan、Sangeeta Dey、Steven W. Johnson、Marisa C. Kozlowski
    DOI:10.1021/ja902324j
    日期:2009.7.8
    The total syntheses of the PKC inhibitors (+)-calphostin D, (+)-phleichrome, cercosporin, and 10 novel perylenequinones are detailed. The highly convergent and flexible strategy developed employed an enantioselective oxidative biaryl coupling and a double cuprate epoxide opening, allowing the selective syntheses of all the possible stereoisomers in pure form. In addition, this strategy permitted rapid
    详细介绍了 PKC 抑制剂 (+)-calphostin D、(+)-phleichrome、尾孢菌素和 10 种新型醌的总合成。开发的高度收敛和灵活的策略采用对映选择性氧化联芳偶联和双环氧化物开环,允许以纯形式选择性合成所有可能的立体异构体。此外,该策略允许快速获取范围广泛的类似物,包括那些无法从天然产品中获取的类似物。这些化合物为评估 PKC 活性所需的醌结构特征提供了强有力的手段。与更复杂的天然产物相比,发现更简单的类似物在癌细胞系中具有优异的 PKC 抑制特性和优异的光增强作用。
  • Total syntheses of phleigchrome, calphostin A, and calphostin D. Unusual stereoselective and stereospecific reactions in the synthesis of perylenequinones
    作者:Chris A. Broka
    DOI:10.1016/s0040-4039(00)92105-1
    日期:1991.2
    This report describes the total synthesis of phleichrome, calphostin A and calphostin D - three protein kinase C inhibitory perylenequinones. The present route affords the targets in enantiomerically pure from and represents the first successful approach to this biologicaly important class of metabolites.
    该报告描述了植物色素,蛋白A和蛋白D的总合成-三种蛋白激酶C抑制per醌。本途径提供了对映体纯的靶标,并代表了这种重要的代谢产物生物学上的成功方法。
  • Perylenequinones from cucumber seedlings infected with Cladosporium cucumerinum
    作者:Alberto Arnone、Gemma Assante、Vincenza Di Modugno、Lucio Merlini、Gianluca Nasini
    DOI:10.1016/0031-9422(88)80424-2
    日期:1988.1
    Abstract The structure of cladochrome A, a perylenequinone pigment isolated from etiolated cucumber seedlings infected with fungal spores of Cladosporium cucumerinum, has been revised and established as that of a diester of 3-hydroxybutyric acid with ent-isophleichrome. Another pigment from the same source, cladochrome B, is the corresponding ester of ent-isophleichrome with 3-hydroxybutyric and benzoic
    摘要 Cladochrome A 是一种从感染了 Cladosporium cucumerinum 真菌孢子的黄化黄瓜幼苗中分离出来的醌色素,其结构已被修改并确定为 3-羟基丁酸与 ent-isophleichrome 的二酯结构。来自同一来源的另一种颜料,cladochrome B,是 ent-isophleichrome 与 3-羟基丁酸苯甲酸的相应酯。
查看更多

同类化合物

苝-3,10-二酮 竹红菌乙素 痂囊腔菌素A 格孢毒素II 格孢毒素I 抑制剂C 卡弗他丁A 4,9-二羟基-6,7-二(2-羟基丙基)-1,5,8,12-四甲氧基苝-3,10-二酮 1-[3,10-二羟基-12-[2-(4-羟基苯甲酰基)氧基丙基]-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基4-羟基苯甲酸酯 1-[3,10-二羟基-12-(2-羟基丙基)-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基苯甲酸酯 (1S,12aR,12bS)-1,2,12a,12b-四氢-1,4,9,12a-四羟基-3,10-苝二酮 Dimethyl 3,10-Dihydro-2,4,6,7,9,11-hexamethoxy-3,10-dioxo-1,12-perylenediacetate Elsinochrome A Alterlosin I 4,10-dihydroxy-5,9-dihydrodinaphtho<2,1-b:1',2'-d>furan-5,9-dione Stemphyltoxin I Acetic acid 6,7,12-triacetoxy-3,10-dihydroxy-4,9-dioxo-4,9-dihydro-perylen-1-yl ester 4,9-Dihydroxy-1,6,7,12-tetramethoxy-perylene-3,10-dione 1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione 1,3,4,6,8,15-Hexahydroxy-10-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-13-methyl-dibenzo[a,o]perylene-7,16-dione Acetic acid 4,9,12-triacetoxy-3,10-dioxo-3,10-dihydro-perylen-1-yl ester Cercosporin, pure 2,11-dihydroxy-4,6,7,9-tetramethoxy-1,12-bis-n-propyl-3,10-perylenequinone 7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2R)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione 2,11-Diamino-perylene-3,10-dione Stemphyltoxin III (3aS)-7,13-dihydroxy-1t,3c,8t,10c-tetramethyl-(3ar,10ac)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronene-6,14-dione [(2S)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate 2,4,6,7,9,11-hexamethoxy-1,12-bis-propyl-3,10-perylenequinone 6-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]hexane-1-sulfonic acid 1,2,5,6-tetrahydroxy-dibenzo[a,o]perylene-7,16-dione calphostin D Phleichrome calphostin A [6-acetyl-8-(3-acetyl-5,7-diacetyloxy-2-methyl-4-oxo-1H-naphthalen-1-yl)-4-acetyloxy-7-methyl-5-oxo-8H-naphthalen-2-yl] acetate (13S)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione 4,9-Dihydroxy-1,5,6,7,8,12-hexamethylperylene-3,10-dione Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester (-)-Phleichrome 1,3,4,6,8,15-Hexahydroxy-9,14-diisopropyl-10,13-dimethoxy-dibenzo[a,o]perylene-7,16-dione 1,6-dihydroxydibenzoperylene-7,16-dione 5-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]pentane-1-sulfonic acid 4-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]butane-1-sulfonic acid Cercosporin (12R,13S)-12-acetyl-9,16-dihydroxy-13-[(1S)-1-hydroxyethyl]-5,10,15,20-tetramethoxyhexacyclo[12.8.0.02,11.03,8.04,21.017,22]docosa-1(14),2(11),3(8),4(21),5,9,15,17(22),19-nonaene-7,18-dione 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone 12-Acetyl-16-(butylamino)-9,17-dihydroxy-5,10,21-trimethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaene-7,19-dione 5,7,11,13,16,18,22,24-Octahydroxy-6,12,17,23-tetramethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-3,5,7,10,12,14(28),15(27),16,18,21,23,25-dodecaene-9,20-dione [(2R)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate [(2S)-1-[3,10-dihydroxy-12-[(2R)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate